Free Trial

Primerica, Inc. (NYSE:PRI) Shares Purchased by iSAM Funds UK Ltd

Primerica logo with Finance background

iSAM Funds UK Ltd grew its stake in Primerica, Inc. (NYSE:PRI - Free Report) by 76.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,950 shares of the financial services provider's stock after purchasing an additional 2,142 shares during the period. Primerica comprises approximately 1.0% of iSAM Funds UK Ltd's investment portfolio, making the stock its 8th largest position. iSAM Funds UK Ltd's holdings in Primerica were worth $1,344,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Barclays PLC grew its stake in shares of Primerica by 108.1% in the third quarter. Barclays PLC now owns 20,471 shares of the financial services provider's stock worth $5,428,000 after purchasing an additional 10,635 shares during the last quarter. HB Wealth Management LLC grew its position in shares of Primerica by 20.6% in the 4th quarter. HB Wealth Management LLC now owns 2,050 shares of the financial services provider's stock valued at $556,000 after buying an additional 350 shares during the last quarter. Artemis Investment Management LLP acquired a new stake in shares of Primerica in the fourth quarter valued at about $5,236,000. UMB Bank n.a. raised its position in shares of Primerica by 65.5% during the fourth quarter. UMB Bank n.a. now owns 240 shares of the financial services provider's stock worth $65,000 after acquiring an additional 95 shares during the last quarter. Finally, Ballentine Partners LLC raised its position in shares of Primerica by 10.9% during the fourth quarter. Ballentine Partners LLC now owns 899 shares of the financial services provider's stock worth $244,000 after acquiring an additional 88 shares during the last quarter. Institutional investors own 90.88% of the company's stock.

Analyst Upgrades and Downgrades

PRI has been the subject of a number of recent analyst reports. Keefe, Bruyette & Woods decreased their target price on shares of Primerica from $320.00 to $315.00 and set a "market perform" rating for the company in a research report on Wednesday, April 9th. Morgan Stanley increased their price objective on shares of Primerica from $274.00 to $296.00 and gave the stock an "equal weight" rating in a research report on Monday. StockNews.com lowered shares of Primerica from a "buy" rating to a "hold" rating in a report on Friday, February 7th. Finally, BMO Capital Markets initiated coverage on Primerica in a report on Thursday, January 23rd. They set a "market perform" rating and a $311.00 price target for the company. Six research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $308.00.

Check Out Our Latest Stock Report on PRI

Insider Buying and Selling at Primerica

In related news, President Peter W. Schneider sold 2,000 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $282.90, for a total value of $565,800.00. Following the completion of the sale, the president now directly owns 13,301 shares of the company's stock, valued at approximately $3,762,852.90. This represents a 13.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Nicholas Adam Jendusa sold 234 shares of Primerica stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $280.15, for a total transaction of $65,555.10. Following the transaction, the insider now directly owns 200 shares in the company, valued at $56,030. This represents a 53.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.61% of the company's stock.

Primerica Trading Up 0.5%

Shares of NYSE PRI opened at $280.39 on Tuesday. The firm has a market capitalization of $9.28 billion, a P/E ratio of 20.39 and a beta of 1.02. The firm's 50-day moving average price is $269.18 and its 200-day moving average price is $280.10. Primerica, Inc. has a 1-year low of $219.52 and a 1-year high of $307.91.

Primerica (NYSE:PRI - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The financial services provider reported $5.02 earnings per share for the quarter, topping analysts' consensus estimates of $4.77 by $0.25. Primerica had a return on equity of 31.11% and a net margin of 15.14%. The business had revenue of $803.56 million for the quarter, compared to the consensus estimate of $783.54 million. During the same period in the prior year, the business earned $3.91 EPS. The firm's revenue for the quarter was up 8.3% on a year-over-year basis. Equities research analysts forecast that Primerica, Inc. will post 20.6 EPS for the current year.

Primerica Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Thursday, May 22nd will be issued a dividend of $1.04 per share. The ex-dividend date is Thursday, May 22nd. This represents a $4.16 annualized dividend and a yield of 1.48%. Primerica's payout ratio is 27.98%.

Primerica Profile

(Free Report)

Primerica, Inc, together with its subsidiaries, provides financial products and services to middle-income households in the United States and Canada. The company operates in four segments: Term Life Insurance; Investment and Savings Products; Senior Health; and Corporate and Other Distributed Products.

Further Reading

Want to see what other hedge funds are holding PRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Primerica, Inc. (NYSE:PRI - Free Report).

Institutional Ownership by Quarter for Primerica (NYSE:PRI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Primerica Right Now?

Before you consider Primerica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Primerica wasn't on the list.

While Primerica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines